3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide hydrochloride

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide hydrochloride
• 英文别名: temanogrel；3-methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)phenyl]benzamide hydrochloride；4-(2-(4-(3-methoxybenzamido)-2-(1-methyl-1H-pyrazol-5-yl)phenoxy)ethyl)morpholin-4-ium chloride；3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ium-4-ylethoxy)phenyl]benzamide;chloride
• 化学式: C₂₄H₂₈N₄O₄*ClH
• 分子量: 472.972
• InChiKey: APWHJJLFCMBWQT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.48
• 重原子数：
  33
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  77.8
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide hydrochloride 在 sodium hydroxide 作用下， 以 水 为溶剂， 反应 1.0h， 生成 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide
  参考文献：
  名称：

  [EN] CRYSTALLINE FORMS OF CERTAIN 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
  [FR] FORMES CRISTALLINES DE CERTAINS DÉRIVÉS DE 3-PHÉNYL-PYRAZOLE, MODULATRICES DU RÉCEPTEUR 5-HT2A DE LA SÉROTONINE, UTILES POUR LE TRAITEMENT DE TROUBLES Y ÉTANT ASSOCIÉS

  摘要：

  提供了3-甲氧基-N-[3-(2-甲基-2H-吡唑-3-基)-4-(2-吗啉-4-基乙氧基)-苯基]-苯甲酰胺的某些溶剂合物或其药用盐。还提供了包含这些溶剂合物的药物组合物以及其使用方法。

  公开号：

  WO2011075596A1
• 作为产物：
  描述：

  2-吗啉乙醇 在 偶氮二甲酸二异丙酯 、 三苯基膦 、 盐酸 作用下， 以 四氢呋喃 、 水 、 异丙醇 为溶剂， 反应 11.0h， 以80%的产率得到3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide hydrochloride
  参考文献：
  名称：

  WO2007/136689

  摘要：

  公开号：

文献信息

• CRYSTALLINE FORMS OF CERTAIN 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
  申请人：Stirn Scott

  公开号：US20120252813A1

  公开（公告）日：2012-10-04

  Provided are certain solvates of 3-methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl]-benzamide or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions comprising such solvates and methods for their use.

  提供了3-甲氧基-N-[3-(2-甲基-2H-吡唑-3-基)-4-(2-吗啡啉-4-基-乙氧基)-苯基]-苯甲酰胺或其药学上可接受的盐的某些溶剂化物。还提供了包含这种溶剂化物的制药组合物以及使用它们的方法。
• CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR
  申请人：Gharbaoui Tawfik

  公开号：US20100234380A1

  公开（公告）日：2010-09-16

  The present invention relates to processes for preparing phenyl-pyrazoles of Formula (I) and salts and pharmaceutical compositions thereof, useful as modulators of 5-HT 2A serotonin receptor activity. The present invention also relates to intermediates used in the processes, and their preparation. The present invention also relates to crystalline forms of 5-HT 2A serotonin receptor modulators, compositions thereof and methods of using the same.

  本发明涉及制备式（I）的苯基吡唑及其盐和药物组合物的过程，它们可用作5-HT2A 5-羟色胺受体活性的调节剂。本发明还涉及用于该过程的中间体及其制备方法。本发明还涉及5-HT2A 5-羟色胺受体调节剂的晶体形式、其组合物及其使用方法。
• Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
  申请人：Gharbaoui Tawfik

  公开号：US08481535B2

  公开（公告）日：2013-07-09

  The present invention relates to processes for preparing phenyl-pyrazoles of Formula (I) and salts and pharmaceutical compositions thereof, useful as modulators of 5-HT2A serotonin receptor activity. The present invention also relates to intermediates used in the processes, and their preparation. The present invention also relates to crystalline forms of 5-HT2A serotonin receptor modulators, compositions thereof and methods of using the same.

  本发明涉及制备式(I)的苯基吡唑及其盐和制药组合物的方法，该物质可用作5-HT2A血清素受体活性调节剂。本发明还涉及用于该过程的中间体及其制备方法。本发明还涉及5-HT2A血清素受体调节剂的晶体形式、组合物及其使用方法。
• Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
  申请人：Stirn Scott

  公开号：US08980891B2

  公开（公告）日：2015-03-17

  Provided are certain solvates of 3-methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl]-benzamide or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions comprising such solvates and methods for their use.

  本发明提供了3-甲氧基-N-[3-(2-甲基-2H-吡唑-3-基)-4-(2-吗啡啉-4-基-乙氧基)-苯基]-苯甲酰胺或其药学上可接受的盐的某些溶剂化物。本发明还提供了包含这样的溶剂化物的制药组合物以及它们的使用方法。
• CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATERS OF THE 5-HT2A SEROTONIN RECEPTOR
  申请人：Arena Pharmaceuticals, Inc.

  公开号：US20180186748A1

  公开（公告）日：2018-07-05

  The present invention relates to processes for preparing phenyl-pyrazoles of Formula (I) and salts and pharmaceutical compositions thereof, useful as modulators of 5-HT 2A serotonin receptor activity. The present invention also relates to intermediates used in the processes, and their preparation. The present invention also relates to crystalline forms of 5-HT 2A serotonin receptor modulators, compositions thereof and methods of using the same.